This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Beth Israel Deaconess Medical Center, Inc.. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Tim Graham: Innovator in Insulin Sensitivity and Resistance
Introduction
Tim Graham is a notable inventor based in Newton Center, MA (US). He has made significant contributions to the field of diabetes and obesity through his innovative research and patents. With a total of 3 patents, Graham's work focuses on understanding and modulating insulin sensitivity and resistance.
Latest Patents
Graham's latest patents revolve around Retinol Binding Protein 4 (RBP4) and its role in insulin sensitivity, resistance, diabetes, and obesity. He has developed methods for screening molecules that can modulate the activity of RBP4. These methods are crucial for treating insulin resistance and diagnosing related conditions by detecting changes in RBP4 activity.
Career Highlights
Tim Graham is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance his research. His work has garnered attention for its potential impact on treating metabolic disorders.
Collaborations
Some of his notable coworkers include Barbara B Kahn and Qin Yang, who have collaborated with him on various research projects.
Conclusion
Tim Graham's innovative work in the field of insulin sensitivity and resistance highlights his importance as an inventor. His contributions are paving the way for new treatments and diagnostic methods in diabetes and obesity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile